Kava [KAVA]

Current Price

$1.54
[-0.9%]

All time High Price

$9.12
[-83.13%]

Market capitalization

$442,561,489

Trading Volume:

$9,462,046

Fully Diluted Market Cap

$220,774,381

Next Token Unlock

Token Sale

Round name Token Price Raised Funds Number of Token sold % of Total Supply Current/ATH ROI Binance Launchpad $0.46 $4,299,652.66 9,347,071 KAVA 6.52% 3.35x / 19.83x Private Sale 3 $0.4 $2,827,058.8 7,067,647 KAVA 4.93% 3.85x / 22.8x Private Sale 1 $0.075 $3,230,975.7 43,079,676 KAVA 30.05% 20.53x / 121.6x Private Sale 2 $0.25 $1,799,167.75 7,196,671 KAVA 5.02% 6.16x / 36.48x Rounds Summary $12,156,854.91 66,691,065 KAVA

Token supply

Initial Market Cap
$9M
Fully diluted Market cap
$220.8M
Current Circulation
76.9M KAVA (54%)
Total supply
143.4M KAVA
Initial price
$0.46
Initial supply
19.6M KAVA
Next Token Unlock
Tokens to be unlocked
KAVA (0%)

Token distribution

Role % of total supply Current Supply Initial Supply Binance Launchpad 6.52% 6.52% 6.52% Token Tresures 28.48% 28.48% 7.12% Private Sale 2 5.02% 5.02% 0% Private Sale 3 4.93% 4.93% 0% Private Sale 1 30.05% 30.05% 0% KAVA Labs Shareholders 25% 25% 0% Summary 100%100%13.64%

Unlock schedule

Passed unlocks
Next unlock
Upcoming unlocks
Role Currently Unlocked (out of 100%) Initial Unlock Unlock % per period Starting from date Full unlock at date Binance Launchpad 100% 100%
0% per MONTH
24-Oct-2019 24-Oct-2019
Token Tresures 100% 25%
02.01.20209.5%
02.04.202013%
02.07.202010%
02.10.202010%
02.01.202110%
1/2 page
24-Oct-2019 2-Oct-2021
Private Sale 2 100% 0%
02.04.202050%
02.07.20208.4%
02.10.20208.5%
02.01.20218.3%
02.04.20218.3%
1/2 page
2-Apr-2020 2-Oct-2021
Private Sale 3 100% 0%
02.04.202050.1%
02.07.20208.32%
02.10.20208.32%
02.01.20218.32%
02.04.20218.32%
1/2 page
2-Apr-2020 2-Oct-2021
Private Sale 1 100% 0%
02.10.202025%
02.01.202118.75%
02.04.202118.75%
02.07.202118.75%
02.10.202118.75%
2-Sep-2020 2-Oct-2021
KAVA Labs Shareholders 100% 0%
02.10.202025.12%
02.01.20219.36%
02.04.20219.36%
02.07.20219.36%
02.10.20219.36%
1/2 page
2-Oct-2020 2-Oct-2022

Team and Advisors

Investors

Related publications